Profile data is unavailable for this security.
About the company
Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.
- Revenue in JPY (TTM)593.29m
- Net income in JPY-982.78m
- Incorporated2005
- Employees47.00
- LocationChiome Bioscience Inc12F,Smtm Fdsn Nshi-shnjk Bldg. No.63-12-1, Hon-machiSHIBUYA-KU 151-0071JapanJPN
- Phone+81 363833561
- Websitehttps://www.chiome.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ribomic Inc | 750.00k | -1.04bn | 4.56bn | 25.00 | -- | 1.42 | -- | 6,085.26 | -22.23 | -22.23 | 0.0159 | 59.35 | 0.0002 | -- | 0.0173 | 30,000.00 | -31.47 | -29.95 | -32.94 | -31.15 | -- | -- | -138,954.00 | -2,725.95 | 20.66 | -- | 0.00 | -- | -- | -55.55 | 0.5173 | -- | -6.86 | -- |
| Modalis Therapeutics Corp | 0.00 | -2.15bn | 5.07bn | 14.00 | -- | 1.80 | -- | -- | -28.13 | -28.13 | 0.00 | 32.23 | 0.00 | -- | -- | -- | -64.69 | -47.62 | -67.23 | -49.48 | -- | -- | -- | -22,365.60 | -- | -- | -- | -- | -- | -- | -63.34 | -- | -68.51 | -- |
| D.Western Therapeutics Institute Inc | 387.62m | -632.09m | 5.53bn | 21.00 | -- | 3.85 | -- | 14.28 | -13.31 | -13.31 | 8.09 | 26.46 | 0.2019 | 0.4115 | 3.53 | -- | -32.93 | -28.15 | -36.09 | -30.68 | 89.97 | 92.09 | -163.07 | -155.99 | 9.48 | -- | 0.2966 | -- | -17.80 | 1.74 | 51.01 | -- | -11.74 | -- |
| Carna Biosciences, Inc. | 579.06m | -2.17bn | 6.24bn | 63.00 | -- | 20.12 | -- | 10.77 | -113.62 | -113.62 | 30.30 | 16.16 | 0.2894 | 1.24 | 6.17 | -- | -108.53 | -37.21 | -120.28 | -41.98 | 67.03 | 86.49 | -375.00 | -118.28 | 6.08 | -75.55 | 0.6979 | -- | -8.99 | -12.57 | 0.3262 | -- | -33.02 | -- |
| TMS Co Ltd | 0.00 | -693.96m | 6.41bn | 18.00 | -- | 2.31 | -- | -- | -15.47 | -15.47 | 0.00 | 60.92 | 0.00 | -- | -- | -- | -24.01 | -- | -24.96 | -- | -- | -- | -- | -- | 30.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cyfuse Biomedical KK | -100.00bn | -100.00bn | 6.61bn | 21.00 | -- | 2.31 | -- | -- | -- | -- | -- | 286.90 | -- | -- | -- | -- | -- | -13.87 | -- | -16.49 | -- | 68.61 | -- | -178.86 | 4.44 | -- | 0.3224 | -- | 324.27 | 10.94 | 12.43 | -- | 182.58 | -- |
| Noile-Immune Biotech Inc | 5.00m | -793.54m | 6.80bn | 25.00 | -- | 1.73 | -- | 1,359.68 | -18.33 | -18.33 | 0.1155 | 90.80 | 0.0011 | -- | 0.1129 | -- | -18.01 | -17.82 | -18.31 | -18.34 | -- | -- | -15,870.72 | -385.41 | 53.51 | -- | -- | -- | -34.10 | -44.77 | 17.72 | -- | -- | -- |
| Tsubota Laboratory Inc | 710.56m | -398.77m | 6.91bn | 17.00 | -- | 6.25 | -- | 9.73 | -15.53 | -15.53 | 27.55 | 42.86 | 0.3594 | 0.4522 | 50.46 | 41,797,700.00 | -20.17 | 0.1041 | -29.56 | 0.1517 | 81.65 | 71.43 | -56.12 | 0.2216 | 2.60 | -- | 0.0634 | 0.00 | 101.49 | 25.17 | 132.08 | 132.70 | 26.42 | -- |
| Linical Co Ltd | 9.32bn | -1.77bn | 7.82bn | 598.00 | -- | 1.26 | -- | 0.8389 | -78.51 | -78.51 | 412.61 | 251.02 | 0.5937 | -- | 3.62 | 15,584,280.00 | -11.30 | 2.59 | -20.50 | 4.19 | 17.48 | 29.24 | -19.03 | 3.74 | -- | -192.93 | 0.2933 | 77.26 | -15.20 | -0.9283 | -259.37 | -- | -42.01 | 4.24 |
| OncoTherapy Science, Inc. | 784.25m | -881.65m | 7.91bn | 47.00 | -- | 3.70 | -- | 10.09 | -2.93 | -2.93 | 2.60 | 5.68 | 0.4224 | 8.38 | 8.72 | 16,686,090.00 | -47.48 | -63.66 | -56.22 | -77.43 | 3.63 | -0.3852 | -112.42 | -184.75 | 8.13 | -832.79 | 0.0043 | -- | 22.93 | 18.86 | 36.71 | -- | -70.80 | -- |
| PRISM BioLab Co Ltd | 684.61m | -927.75m | 8.16bn | 35.00 | -- | 3.35 | -- | 11.92 | -25.27 | -25.27 | 18.64 | 66.06 | 0.1886 | -- | 8.79 | 19,560,140.00 | -25.55 | -- | -32.06 | -- | 38.47 | -- | -135.52 | -- | -- | -77.05 | 0.00 | -- | 121.62 | -- | 20.56 | -- | -- | -- |
| Medinet Co Ltd | 787.09m | -1.36bn | 8.27bn | 107.00 | -- | 2.39 | -- | 10.50 | -5.12 | -5.12 | 2.97 | 12.95 | 0.1701 | 11.08 | 3.00 | 7,355,991.00 | -29.29 | -22.42 | -31.04 | -23.64 | 13.58 | 17.68 | -172.25 | -173.59 | 11.33 | -- | 0.00 | -- | 5.44 | 0.6867 | -6.67 | -- | 10.06 | -- |
| Chiome Bioscience Inc | 593.29m | -982.78m | 8.61bn | 47.00 | -- | 7.56 | -- | 14.52 | -14.48 | -14.48 | 8.74 | 16.39 | 0.2828 | 4.97 | 9.64 | -- | -46.84 | -52.22 | -59.06 | -64.41 | 59.93 | 57.59 | -165.65 | -174.88 | 3.99 | -1,177.61 | 0.1891 | -- | -24.02 | 4.29 | 3.72 | -- | -- | -- |
| Chordia Therapeutics Inc | 0.00 | -1.46bn | 8.82bn | 20.00 | -- | 3.70 | -- | -- | -21.23 | -21.23 | 0.00 | 32.67 | 0.00 | -- | -- | 0.00 | -46.77 | -- | -49.97 | -- | -- | -- | -- | -- | -- | -222.95 | 0.00 | -- | -- | -- | 2.26 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 1.11m | -1.08bn | 9.49bn | 24.00 | -- | 5.25 | -- | 8,547.08 | -11.59 | -11.59 | 0.0117 | 13.70 | 0.0007 | -- | -- | 46,250.00 | -63.35 | -59.65 | -74.36 | -63.78 | 97.66 | 73.74 | -96,860.36 | -28,727.67 | -- | -1,103.91 | 0.00 | -- | 1,473.61 | -36.87 | 1.45 | -- | -58.41 | -- |
Data as of Feb 20 2026. Currency figures normalised to Chiome Bioscience Inc's reporting currency: Japanese Yen JPY
0.24%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 05 Feb 2026 | 163.60k | 0.24% |
Data from 05 Feb 2026 - 05 Feb 2026Source: FactSet Research Systems Inc.
